Titre : bêta-Arrestines

bêta-Arrestines : Questions médicales fréquentes

Termes MeSH sélectionnés :

Developing Countries
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "bêta-Arrestines : Questions médicales les plus fréquentes", "headline": "bêta-Arrestines : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les bêta-Arrestines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-02", "dateModified": "2025-03-28", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "bêta-Arrestines" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Arrestines", "url": "https://questionsmedicales.fr/mesh/D019390", "about": { "@type": "MedicalCondition", "name": "Arrestines", "code": { "@type": "MedicalCode", "code": "D019390", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.090" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "bêta-Arrestine 1", "alternateName": "beta-Arrestin 1", "url": "https://questionsmedicales.fr/mesh/D000071559", "about": { "@type": "MedicalCondition", "name": "bêta-Arrestine 1", "code": { "@type": "MedicalCode", "code": "D000071559", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.090.525.500" } } }, { "@type": "MedicalWebPage", "name": "bêta-Arrestine 2", "alternateName": "beta-Arrestin 2", "url": "https://questionsmedicales.fr/mesh/D000071560", "about": { "@type": "MedicalCondition", "name": "bêta-Arrestine 2", "code": { "@type": "MedicalCode", "code": "D000071560", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.090.525.750" } } } ], "about": { "@type": "MedicalCondition", "name": "bêta-Arrestines", "alternateName": "beta-Arrestins", "code": { "@type": "MedicalCode", "code": "D000071557", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Vsevolod V Gurevich", "url": "https://questionsmedicales.fr/author/Vsevolod%20V%20Gurevich", "affiliation": { "@type": "Organization", "name": "Department of Pharmacology, Vanderbilt University, Nashville, TN, United States of America." } }, { "@type": "Person", "name": "Eugenia V Gurevich", "url": "https://questionsmedicales.fr/author/Eugenia%20V%20Gurevich", "affiliation": { "@type": "Organization", "name": "Department of Pharmacology, Vanderbilt University, Nashville, Tennessee." } }, { "@type": "Person", "name": "Sergey A Vishnivetskiy", "url": "https://questionsmedicales.fr/author/Sergey%20A%20Vishnivetskiy", "affiliation": { "@type": "Organization", "name": "Department of Pharmacology, Vanderbilt University, Nashville, TN, United States of America." } }, { "@type": "Person", "name": "Robert J Lefkowitz", "url": "https://questionsmedicales.fr/author/Robert%20J%20Lefkowitz", "affiliation": { "@type": "Organization", "name": "Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA; Department of Biochemistry, Duke University Medical Center, Durham, North Carolina, USA; Howard Hughes Medical Institute, Duke University Medical Center, Durham, North Carolina, USA. Electronic address: lefko001@receptor-biol.duke.edu." } }, { "@type": "Person", "name": "Ka Young Chung", "url": "https://questionsmedicales.fr/author/Ka%20Young%20Chung", "affiliation": { "@type": "Organization", "name": "School of Pharmacy, Sungkyunkwan University, 2066 Seoburo, Jangan-gu, Suwon, 16419, Republic of Korea. kychung2@skku.edu." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Ensuring environmental inclusion in developing countries: the role of macroeconomic policies.", "datePublished": "2022-12-07", "url": "https://questionsmedicales.fr/article/36474034", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11356-022-24596-z" } }, { "@type": "ScholarlyArticle", "name": "Evaluating the quality of health technology assessment reports in a developing country.", "datePublished": "2023-07-31", "url": "https://questionsmedicales.fr/article/37553743", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.26719/emhj.22.017" } }, { "@type": "ScholarlyArticle", "name": "Investigating the impact of air pollution in selected African developing countries.", "datePublished": "2023-04-17", "url": "https://questionsmedicales.fr/article/37067712", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11356-023-26998-z" } }, { "@type": "ScholarlyArticle", "name": "The national health program for vitamin D supplementation in a developing country.", "datePublished": "2023-01-20", "url": "https://questionsmedicales.fr/article/36963898", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clnesp.2023.01.012" } }, { "@type": "ScholarlyArticle", "name": "Addressing vaccine hesitancy in developing countries: Survey and experimental evidence.", "datePublished": "2022-11-17", "url": "https://questionsmedicales.fr/article/36395260", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0277493" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines membranaires", "item": "https://questionsmedicales.fr/mesh/D008565" }, { "@type": "ListItem", "position": 5, "name": "Arrestines", "item": "https://questionsmedicales.fr/mesh/D019390" }, { "@type": "ListItem", "position": 6, "name": "bêta-Arrestines", "item": "https://questionsmedicales.fr/mesh/D000071557" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : bêta-Arrestines - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur bêta-Arrestines", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur bêta-Arrestines", "description": "Comment diagnostiquer une dysfonction des bêta-arrestines ?\nQuels tests sont utilisés pour évaluer les bêta-arrestines ?\nLes bêta-arrestines peuvent-elles être mesurées dans le sang ?\nQuels biomarqueurs sont associés aux bêta-arrestines ?\nLes bêta-arrestines sont-elles impliquées dans des maladies spécifiques ?", "url": "https://questionsmedicales.fr/mesh/D000071557?mesh_terms=Developing+Countries&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur bêta-Arrestines", "description": "Quels symptômes sont liés à une dysfonction des bêta-arrestines ?\nLes bêta-arrestines affectent-elles le métabolisme ?\nPeut-on observer des effets neurologiques liés aux bêta-arrestines ?\nLes bêta-arrestines sont-elles liées à des douleurs chroniques ?\nY a-t-il des symptômes associés à des médicaments ciblant les bêta-arrestines ?", "url": "https://questionsmedicales.fr/mesh/D000071557?mesh_terms=Developing+Countries&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur bêta-Arrestines", "description": "Comment prévenir les dysfonctionnements des bêta-arrestines ?\nY a-t-il des habitudes à éviter pour protéger les bêta-arrestines ?\nL'exercice physique influence-t-il les bêta-arrestines ?\nUne alimentation riche en antioxydants aide-t-elle les bêta-arrestines ?\nLe stress a-t-il un impact sur les bêta-arrestines ?", "url": "https://questionsmedicales.fr/mesh/D000071557?mesh_terms=Developing+Countries&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur bêta-Arrestines", "description": "Quels traitements ciblent les bêta-arrestines ?\nLes bêta-arrestines peuvent-elles être une cible thérapeutique ?\nComment les bêta-arrestines sont-elles modulées par les médicaments ?\nY a-t-il des approches naturelles pour influencer les bêta-arrestines ?\nLes bêta-arrestines sont-elles impliquées dans des thérapies géniques ?", "url": "https://questionsmedicales.fr/mesh/D000071557?mesh_terms=Developing+Countries&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur bêta-Arrestines", "description": "Quelles complications peuvent survenir avec des bêta-arrestines dysfonctionnelles ?\nLes bêta-arrestines sont-elles liées à des cancers ?\nPeut-on développer des maladies neurodégénératives liées aux bêta-arrestines ?\nLes complications cardiovasculaires sont-elles liées aux bêta-arrestines ?\nLes troubles métaboliques peuvent-ils être causés par des bêta-arrestines ?", "url": "https://questionsmedicales.fr/mesh/D000071557?mesh_terms=Developing+Countries&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur bêta-Arrestines", "description": "Quels facteurs de risque influencent les bêta-arrestines ?\nL'âge affecte-t-il la fonction des bêta-arrestines ?\nLe régime alimentaire impacte-t-il les bêta-arrestines ?\nLe stress psychologique influence-t-il les bêta-arrestines ?\nLes facteurs génétiques jouent-ils un rôle dans les bêta-arrestines ?", "url": "https://questionsmedicales.fr/mesh/D000071557?mesh_terms=Developing+Countries&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction des bêta-arrestines ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses de signalisation cellulaire peuvent être utilisés." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les bêta-arrestines ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests d'immunoblot et de fluorescence sont couramment utilisés." } }, { "@type": "Question", "name": "Les bêta-arrestines peuvent-elles être mesurées dans le sang ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de tests sanguins standardisés pour les bêta-arrestines." } }, { "@type": "Question", "name": "Quels biomarqueurs sont associés aux bêta-arrestines ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les niveaux de certaines cytokines peuvent indiquer une activité des bêta-arrestines." } }, { "@type": "Question", "name": "Les bêta-arrestines sont-elles impliquées dans des maladies spécifiques ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont liées à des maladies comme l'obésité et les troubles cardiovasculaires." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une dysfonction des bêta-arrestines ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes variés comme l'inflammation et des troubles métaboliques peuvent apparaître." } }, { "@type": "Question", "name": "Les bêta-arrestines affectent-elles le métabolisme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles jouent un rôle clé dans la régulation du métabolisme énergétique." } }, { "@type": "Question", "name": "Peut-on observer des effets neurologiques liés aux bêta-arrestines ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont impliquées dans la signalisation neuronale et peuvent affecter la cognition." } }, { "@type": "Question", "name": "Les bêta-arrestines sont-elles liées à des douleurs chroniques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent moduler la douleur en influençant les voies de signalisation de la douleur." } }, { "@type": "Question", "name": "Y a-t-il des symptômes associés à des médicaments ciblant les bêta-arrestines ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des effets secondaires comme des nausées ou des vertiges peuvent survenir." } }, { "@type": "Question", "name": "Comment prévenir les dysfonctionnements des bêta-arrestines ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, est recommandé." } }, { "@type": "Question", "name": "Y a-t-il des habitudes à éviter pour protéger les bêta-arrestines ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabagisme et la consommation excessive d'alcool peut aider à leur préservation." } }, { "@type": "Question", "name": "L'exercice physique influence-t-il les bêta-arrestines ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer leur fonction et réduire les risques de maladies." } }, { "@type": "Question", "name": "Une alimentation riche en antioxydants aide-t-elle les bêta-arrestines ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antioxydants peuvent protéger les cellules et améliorer la signalisation." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur les bêta-arrestines ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut altérer leur fonction et contribuer à des maladies." } }, { "@type": "Question", "name": "Quels traitements ciblent les bêta-arrestines ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les bêta-bloquants peuvent influencer leur activité." } }, { "@type": "Question", "name": "Les bêta-arrestines peuvent-elles être une cible thérapeutique ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont considérées comme des cibles potentielles pour de nouveaux traitements." } }, { "@type": "Question", "name": "Comment les bêta-arrestines sont-elles modulées par les médicaments ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les médicaments peuvent augmenter ou diminuer leur activité en modulant les récepteurs." } }, { "@type": "Question", "name": "Y a-t-il des approches naturelles pour influencer les bêta-arrestines ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certaines plantes médicinales peuvent moduler leur activité, mais des études sont nécessaires." } }, { "@type": "Question", "name": "Les bêta-arrestines sont-elles impliquées dans des thérapies géniques ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent être ciblées dans des approches de thérapie génique pour certaines maladies." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des bêta-arrestines dysfonctionnelles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme l'obésité, le diabète et des maladies cardiovasculaires peuvent survenir." } }, { "@type": "Question", "name": "Les bêta-arrestines sont-elles liées à des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des études suggèrent qu'elles peuvent influencer la progression de certains cancers." } }, { "@type": "Question", "name": "Peut-on développer des maladies neurodégénératives liées aux bêta-arrestines ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines recherches indiquent un lien entre leur dysfonction et des maladies comme Alzheimer." } }, { "@type": "Question", "name": "Les complications cardiovasculaires sont-elles liées aux bêta-arrestines ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles jouent un rôle dans la régulation de la pression artérielle et de la fonction cardiaque." } }, { "@type": "Question", "name": "Les troubles métaboliques peuvent-ils être causés par des bêta-arrestines ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une régulation anormale des bêta-arrestines peut entraîner des troubles métaboliques." } }, { "@type": "Question", "name": "Quels facteurs de risque influencent les bêta-arrestines ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'obésité, le diabète et le mode de vie sédentaire sont des facteurs de risque importants." } }, { "@type": "Question", "name": "L'âge affecte-t-il la fonction des bêta-arrestines ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut altérer leur fonction et augmenter le risque de maladies." } }, { "@type": "Question", "name": "Le régime alimentaire impacte-t-il les bêta-arrestines ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en graisses saturées peut nuire à leur fonction." } }, { "@type": "Question", "name": "Le stress psychologique influence-t-il les bêta-arrestines ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut perturber leur signalisation et contribuer à des maladies." } }, { "@type": "Question", "name": "Les facteurs génétiques jouent-ils un rôle dans les bêta-arrestines ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des variations génétiques peuvent affecter leur expression et leur fonction." } } ] } ] }

Sources (10000 au total)

Evaluating the quality of health technology assessment reports in a developing country.

No single method of health technology assessment (HTA) can meet all the policy- and decision-making needs in a country. However, there should be minimum criteria for performing HTA worldwide, and many... This study aimed to assess the quality of HTA reports in the Islamic Republic of Iran.... We examined all the HTA research reports published by the Iranian HTA office up to 2020, using the International Network of Agencies for Health Technology Assessment checklist for quality assessment.... A total of 97 reports were examined, of which only 10.0% provided complete and appropriate contact details for further information and 5.6% clearly stated a conflict of interest. In 87.78% of the repo... We recommend that minimum standards be established for the HTA process so that healthcare policy- and decision-makers can make reliable decisions on the basis of the HTA reports....

The national health program for vitamin D supplementation in a developing country.

Previous studies have reported a high frequency of vitamin D deficiency (VDD) among different age groups in Iran.... In this study, the current coverage, status of vitamin D supplement taking, and program efficacy have been evaluated by the Office of Nutrition Department Society in Iran since 2014.... This study was conducted in collaboration with the International UNESCO center for Health-Related Basic Sciences and Human Nutrition and the Office of Nutrition Department Society. Sixty three medical... Quantitative analysis showed that availability coverage was 74.96% and 77.56% and accessibility was 80.70% and 83.26% in elderly and middle-aged subjects, respectively in 2018. The acceptability was a... The frequency of taking vitamin D supplements was 27.0% in Iran in 2018. The frequency of taking of vitamin D supplements among vitamin D deficient group (serum vitamin D levels <19.99 ng/ml) was 43.6...

Outcomes of burns patients in a developing country: A single centre's experience.

Pelonomi Tertiary Hospital is the only hospital in the Free State Province with a burns unit. We do not have official data to assess our performance in the management of burns.... To determine the Lethal Area 50 (LA50) index for the Pelonomi Tertiary Hospital's burns unit. Furthermore, to determine the morbidity that affects burns patients at the institution, and the factors as... We used Redcap to capture demographic and clinical data of burn patients admitted to our institution between January 2014 and December 2018. Logistic regression was used to determine significant predi... Our study had a male preponderance, with 59.7% (601) male, 39.9% (401) female and 0.4% (4) missing sex. We had a mean age of 19.4 years, of which 53.38% (n=537) were paediatric patients and 46.32% (n=... The epidemiology of burn patients and working conditions at Pelonomi Tertiary Hospital are similar to other burn units in the country; however, our mortality rate is higher than at most centres. The L...

Technical aspects of inguino scrotal hernia surgery in developing countries.

Technical aspects of inguinoscrotal herniorrhaphy performed in low to middle income countries (LMICs) are described here to help surgeons who will operate on these challenging hernias in austere setti... Technical considerations related to operative repair were delineated with the consensus of 7 surgeons with extensive experience in inguinoscrotal hernia repair in LMICs. Important steps and illustrati... The authors have cumulatively performed over 1775 inguinoscrotal Lichtenstein operations in LMICs. While dedicated, reliable, long-term follow-up is unavailable from LMICs, one author reports outcomes... There is a difference between inguinal hernias found in LMICs and those seen in high-income countries with larger, chronic, and more technically challenging pathology. The consequences of intra-operat...

Internet use and frailty in middle-aged and older adults: findings from developed and developing countries.

With increasing trend of internet use in all age groups, whether internet use can prevent frailty in middle-aged and older adults remains unclear.... Five cohorts, including Health and Retirement Study (HRS), China Health and Retirement Longitudinal Study (CHARLS), the Survey of Health, Ageing and Retirement in Europe (SHARE), English Longitudinal ... In the multicohort study, a total of 155,695 participants were included in main analysis. The proportion of internet use was varied across countries, ranging from 5.56% in China (CHARLS) to 83.46% in ... Our findings highlight the important role of internet use in preventing frailty and recommend more engagements in social communication and activities to avoid social isolation among middle-aged and ol...